Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis

Conclusions: Patient-derived rapamycin-expanded CD25+ cells are stable and functional, and as such, ready to serve in a phase I dose-escalation safety study in UC.
Source: Inflammatory Bowel Diseases - Category: Gastroenterology Tags: Original Basic Science Articles Source Type: research